Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haleon Plc on January 2, 2026, for the month of January 2026. Haleon is a global leader in consumer health with a portfolio spanning six categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health and Other. The filing primarily discloses capital structure and voting rights data as of December 31, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on share capital and voting rights.
Material Changes and Capital Structure
As of December 31, 2025, the Company's capital structure is as follows:
- Total Ordinary Shares Issued: 8,952,353,648 shares of £0.01 each.
- Treasury Shares: 45,745,646 shares held by the Company.
- Shares with Voting Rights: 8,906,608,002 shares.
The number of shares with voting rights serves as the denominator for shareholders to calculate notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is a routine disclosure of voting rights and capital.
Key Facts for Investor Verification
- Verify the denominator for disclosure obligations is 8,906,608,002 voting shares as of December 31, 2025.
- Confirm the total issued share count of 8,952,353,648 includes 45,745,646 treasury shares.
- Note that this filing contains no financial performance data; refer to Form 20-F for comprehensive financial results.